Q32 Bio Inc (NASDAQ: QTTB) on Friday, plunged -12.94% from the previous trading day, before settling in for the closing price of $4.25. Within the past 52 weeks, QTTB’s price has moved between $4.17 and $53.79.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 199.24% over the past five years. The company achieved an average annual earnings per share of 25.44%. With a float of $4.63 million, this company’s outstanding shares have now reached $12.14 million.
Let’s look at the performance matrix of the company that is accounted for 7 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Q32 Bio Inc (QTTB) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Q32 Bio Inc is 61.97%, while institutional ownership is 31.78%. The most recent insider transaction that took place on Mar 25 ’24, was worth 6,413. In this transaction Director of this company sold 265 shares at a rate of $24.20, taking the stock ownership to the 7,983 shares. Before that another transaction happened on Mar 25 ’24, when Company’s insider sold 268 for $24.21, making the entire transaction worth $6,488. This insider now owns 2,596 shares in total.
Q32 Bio Inc (QTTB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 25.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -9.40% during the next five years compared to -0.07% drop over the previous five years of trading.
Q32 Bio Inc (NASDAQ: QTTB) Trading Performance Indicators
Q32 Bio Inc (QTTB) is currently performing well based on its current performance indicators. A quick ratio of 6.53 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.21, a number that is poised to hit -1.53 in the next quarter and is forecasted to reach -4.14 in one year’s time.
Technical Analysis of Q32 Bio Inc (QTTB)
Q32 Bio Inc (NASDAQ: QTTB) saw its 5-day average volume 1.67 million, a positive change from its year-to-date volume of 0.11 million. As of the previous 9 days, the stock’s Stochastic %D was 0.38%. Additionally, its Average True Range was 4.03.
During the past 100 days, Q32 Bio Inc’s (QTTB) raw stochastic average was set at 0.06%, which indicates a significant decrease from 0.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 580.61% in the past 14 days, which was higher than the 241.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $37.17, while its 200-day Moving Average is $30.85. Nevertheless, the first resistance level for the watch stands at $4.18 in the near term. At $4.67, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.92. If the price goes on to break the first support level at $3.44, it is likely to go to the next support level at $3.19. The third support level lies at $2.70 if the price breaches the second support level.
Q32 Bio Inc (NASDAQ: QTTB) Key Stats
Market capitalization of the company is 39.24 million based on 12,181K outstanding shares. Right now, sales total 1,160 K and income totals -112,960 K. The company made 0 K in profit during its latest quarter, and -17,600 K in sales during its previous quarter.
